Ultrasound protocols to measure carotid intima-media thickness: A post-hoc analysis of the OPAL study

Current Medical Research and Opinion

Volumn 25, Issue 1, 2009, Pages 109-122

  Dogan, S ^a   Plantinga, Y ^a   Evans, G W ^b   Meijer, R ^c   Grobbee, D E ^a   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c BioClinica Inc   (United States)

Author keywords

Carotid intima; Core laboratory; Epidemiology; Media thickness; Methodology; Reproducibility

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; TIBOLONE; ESTROGEN; PLACEBO; PREGNANE DERIVATIVE;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; B SCAN; CLINICAL STUDY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; NORMAL HUMAN; POST HOC ANALYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; ARTICLE; CAROTID ARTERY; ECHOGRAPHY; INTIMA; METHODOLOGY;

CAROTID ARTERIES; DOUBLE-BLIND METHOD; ESTROGENS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; NORPREGNENES; PLACEBOS; REPRODUCIBILITY OF RESULTS; TUNICA INTIMA; ULTRASONOGRAPHY;

EID: 64249096229     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802589727     Document Type: Conference Paper

References (27)

1. Cardellini M, Marini MA, Frontoni S, et al. Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2007; 292:E347-52 (Pubitemid 46052960)
2. Johnson HM, Douglas PS, Srinivasan SR, et al. Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. Stroke 2007;38:900-905 (Pubitemid 46568450)
3. Lopes-Virella MF, McHenry MB, Lipsitz S, et al. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis 2007;190:359-369 (Pubitemid 46074026)
4. Touboul PJ, Labreuche J, Vicaut E, et al. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke 2005;36:1741-1745 (Pubitemid 41098773)
5. Sawayama Y, Shimizu C, Maeda N, et al. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). J Am Coll Cardiol 2002;39:610-616 (Pubitemid 34158156)
6. Taylor AJ, Sullenberger LE, Lee HJ, et al. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004;110:3512-3517
7. Zanchetti A, Crepaldi G, Bond MG, et al. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS - a randomized double-blind trial. Stroke 2004;35:2807-2812 (Pubitemid 39565175)
8. Anderssen SA, Hjelstuen AK, Hjermann I, et al. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. Atherosclerosis 2005;178:387-397 (Pubitemid 40193456)
9. Asselbergs FW, van Roon AM, Hillege HL, et al. Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria. Stroke 2005;36:649-653 (Pubitemid 40344172)
10. Bots ML, Visseren FL, Evans GW, et al. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 2007;370:153-160 (Pubitemid 47042895)
11. Crouse JR, III, Raichlen JS, Riley WA, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297:1344-1353 (Pubitemid 46513235)
12. Furberg CD, Adams HP Jr, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994;90:1679-1687 (Pubitemid 24320914)
13. Crouse JR, III, Byington RP, Bond MG, et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol 1995;75:455-459
14. de Groot E, Jukema JW, Montauban van Swijndregt AD, et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 1998;31:1561-1567 (Pubitemid 28273299)
15. Beishuizen ED, van de Ree MA, Jukema JW, et al. Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care 2004;27:2887-2892 (Pubitemid 39565054)
16. Takahashi T, Ishii N, Itai K, et al. HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients. J Atheroscler Thromb 2005;12:149-153
17. Yamanaka Y, Matsuo H, Kurachi O, et al. Effects of combined estriol/pravastatin therapy on intima-media thickness of common carotid artery in hyperlipidemic postmenopausal women. Gynecol Obstet Invest 2005;59:67-69 (Pubitemid 40868072)
18. Taylor AJ, Lee HJ, Sullenberger LE. The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3. Curr Med Res Opin 2006;22:2243-2250 (Pubitemid 44789989)
19. Devine PJ, Turco MA, Taylor AJ. Design and Rationale of the ARBITER 6 Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS). Cardiovasc Drugs Ther 2007;21:221-225
20. Taylor AJ, Zhu D, Sullenberger LE, et al. Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2. Vasc Health Risk Manag 2007;3:159-164 (Pubitemid 46860725)
21. Yu CM, Zhang Q, Lam L, et al. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal- medial thickness in patients with coronary heart disease. Heart 2007;93:933-939 Epub 2007 Mar 7 (Pubitemid 47122042)
22. Bots ML, Evans GW, Riley WH, et al. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study. Eur Heart J 2006;27:746-755
23. Wikstrand J. Methodological considerations of ultrasound measurement of carotid artery intima-media thickness and lumen diameter. Clin Physiol Funct Imaging 2007;27:341-345 (Pubitemid 47604417)
24. Pignoli P, Tremoli E, Oreste P, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-1406 (Pubitemid 17189260)
25. Wong M, Edelstein J, Wollman J, et al. Ultrasonic-pathological comparison of the human arterial wall. Verification of intimamedia thickness. Arterioscler Thromb 1993;13:482-486
26. Espeland MA, Evans GW, Wagenknecht LE, et al. Site-specific progression of carotid artery intimal-medial thickness. Atherosclerosis 2003;171:137-143 (Pubitemid 37464639)
27. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-269 (Pubitemid 28090756)